Monte Rosa Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$19.39

-0.42 (-2.12%)

As of May 10, 10:07 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +98.3% upside

Low Target $28.40

Average Target $38.45

High Target $50.36

Current Price $19.39

Current
$19.39

Target
$38.45

$28.40 $38.45 avg $50.36

Scenario Analysis

Bear Case

$28.40

46.5%

Low target

Base Case

$38.45

+98.3%

Avg target

Bull Case

$50.36

+159.7%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$25.77

-24.8% from high

52-Week Low

$3.51

+452.4% from low

Target vs 52W High

$38.45

+49.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%